Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Adolescent, Adult, alleviate, analyzed, AYA, borrow, borrowing, Capriata, categorized, closer, condensed, CT, cybersecurity, Darien, debtor, deficiency, disaggregated, disaggregation, EC, enclosed, Euro, Floor, Frederick, front, Golden, implicit, intelligence, landscape, leasehold, mentioned, NCCN, Norgine, overstated, revisited, Road, Roberto, SOC, specialist, subtracted, threat, Tucker, unaudited, unrestricted
Removed:
Artali, attest, brain, breakthrough, Chapman, chose, collusion, COSO, daily, detection, diligence, disabling, division, exert, fast, filer, frequent, Mario, Middle, Millennium, neck, occurred, origination, ovarian, override, Overview, partnering, plaintiff, preliminary, project, prospectively, rapidly, remotely, resubmission, rolling, spread, surge, testicular, tradename, undergoing, USD, violated, vulnerability
Filing tables
Filing exhibits
Related press release
FENC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-221091 and 333-232353) and the Registration Statements on Form S-3 (File Nos. 333-268632, 333-219884 and 333-249775) of Fennec Pharmaceuticals Inc. (the “Company”) of our report dated March 29, 2024, relating to the consolidated financial statements as of December 31, 2023 and 2022 and for each of the years then ended, which appear in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
/s/ Haskell & White LLP
HASKELL & WHITE LLP
Irvine, California
March 29, 2024